Sectorally, buying was seen in realty, IT, metal, auto, and healthcare stocks, while selling pressure was seen in the banking space. Stocks that were in focus include names like AstraZeneca Pharma, which rose more than 13% to hit a fresh high, Caplin Point, which gained more than 8%, and JB Chemicals, which closed with gains of over 9% to hit a fresh record high.
8 midcap stocks clock up to 245% EBITDA growth in June quarter. Do you own any?
Eight NSE midcap stocks reported year-on-year EBITDA growth of more than 80% in the June 2026 quarter. Lloyds Metals & Energy led the list with